MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Pilot study to investigate the use of in-clinic sensing to identify optimal stimulation parameters for deep brain stimulation therapy in Parkinson’s disease

    S. Lewis, S. Ojemann, D. Kramer, L. Hirt, E. Radcliffe, M. Case, A. Becker, R. Raike, J. Thompson, D. Kern (Boulder, USA)

    Objective: Compare the use of in-clinic sensing functionality and standard of care monopolar review for identifying optimal settings of a deep brain stimulation (DBS) in…
  • 2022 International Congress

    Parkin deficiency impairs mtDNA dynamics and propagates inflammation

    K. Wasner, S. Smajić, J. Ghelfi, S. Delcambre, C. Prada-Medina, E. Knappe, G. Arena, P. Mulica, G. Agyeah, A. Rakovic, I. Boussaad, K. Badanjak, J. Ohnmacht, J. Gérardy, M. Takanashi, J. Trinh, M. Mittelbronn, N. Hattori, C. Klein, P. Antony, P. Seibler, M. Spielmann, S. Pereira, A. Grünewald (Belvaux, Luxembourg)

    Objective: We sought to explore Parkin’s role in (i) averting neuronal mtDNA dyshomeostasis/release and (ii) the activation of downstream inflammatory processes. Background: Mutations in Parkin…
  • 2022 International Congress

    Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

    C. Gonzalez-Robles, M. Bartlett, M. Burnell, R. Chapman, R. Chaudhuri, C. Clarke, R. Ellis-Doyle, M. Hu, B. Huxford, A. Jha, M. Lawton, G. Mills, A. Noyce, P. Piccini, L. Rochester, J. Rudiger, C. Siu, D. van Wamelen, C. Williams-Gray, ML. Zeissler, H. Zetterberg, C. Carroll, T. Foltynie, R. Weil, A. Schrag (London, United Kingdom)

    Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatment for…
  • 2022 International Congress

    Oligomeric alpha-synuclein in reflex tears and retinal changes in Parkinson’s disease

    A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Hernández-Medrano, S. Somilleda-Ventura, H. Perez-Cano, O. Guerrero-Berger (Mexico, Mexico)

    Objective: To compare oligomeric alpha-synuclein (α-Syn) in reflex tears and its association with the thickness of retinal layers in Parkinson’s disease (PD) Background: Alpha-synuclein is…
  • 2022 International Congress

    Effects of Parkinson’s disease and freezing of gait on the kinematic and kinetic gait parameters

    D. Campos, T. Shida, C. Oliveira, R. Treza, S. Hondo, E. Los Angeles, C. Bernardo, L. Oliveira, M. Carvalho, D. Coelho (São Bernardo Campos, Brazil)

    Objective: This study aims to evaluate the effects of Parkinson's disease and freezing of gait (FoG) on the kinematic and kinetic gait parameters, both in…
  • 2022 International Congress

    Evaluation of ocular perfusion in Parkinson’s disease and association with clinical manifestations.

    A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Hernández-Medrano, O. Guerrero-Berger (Mexico, Mexico)

    Objective: To evaluate optic nerve head and macular perfusion in subjects with Parkinson's disease (PD) and its association with clinical manifestations. Background: PD is associated…
  • 2022 International Congress

    Validation of the English version of the Parkinson Anxiety Scale in the Canadian population: Interim results

    J. Lam, X. Tang, D. Meng, P. Uzelman, A. Yu, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To validate the use of the English version of the PAS in Parkinson’s disease (PD) patients in Canada. Background: The PAS, originally developed to…
  • 2022 International Congress

    Perturbation-based balance training in individuals with Parkinson’s disease and freezing of gait

    DB. Coelho, C. Ribeiro Souza, J. ávila Oliveira, L. Rezende, P. Takazono, C. Silva-Batista, L. Teixeira (São Bernardo Campo, Brazil)

    Objective: In the current study, we assessed the effect of a multisession training program based on unpredictable AP and ML perturbations of body balance on…
  • 2022 International Congress

    Impact of SARS-CoV-2 vaccine in Parkinson’s disease

    E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, P. Bazán-Rodríguez, MA. Ruiz-Mafud, AJ. Hernández-Medrano, GI. Cerda-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To evaluate the impact of SARS-CoV-2 vaccine on motor and non-motor symptoms in Mexican people with Parkinson's disease (PwP). Background: Nowadays, as a consequence…
  • 2022 International Congress

    Fundamental changes in Nerve Conduction Velocity and hyperpolarization latency of action potential of Sciatic nerve at the pre-motor phase in a chronic PD in vivo model: a neurotool for Parkinson’s disease diagnosis

    I. Datta, K. Mondal, A. Kaushal (Bengaluru, India)

    Objective: To evaluate the changes in NCV and hyperpolarization latency of action potential of Sciatic nerve at the pre-motor phase in MPTP induced chronic PD…
  • « Previous Page
  • 1
  • …
  • 234
  • 235
  • 236
  • 237
  • 238
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley